Skip to main content
ADDvise Group B logo

ADDvise Group B — Investor Relations & Filings

Ticker · ADDV ISIN · SE0001306119 LEI · 549300C17TZXE1IEOA66 ST Wholesale and retail trade
Open in API
Filings indexed 399 across all filing types
Latest filing 2024-05-02 Board/Management Inform…
Country SE Sweden
Listing ST ADDV

About ADDvise Group B

https://www.addvisegroup.com/

ADDvise Group is an international life science company that provides comprehensive solutions, including products and services, to the healthcare and research sectors. The group operates through two primary business areas: Lab and Healthcare. The Lab division supplies laboratory equipment, furnishings, and consumables to public and private research facilities. The Healthcare division offers medical devices and equipment to various healthcare providers. ADDvise Group expands through the acquisition and development of high-quality companies, utilizing a decentralized ownership model that allows its subsidiaries to operate with autonomy while benefiting from corporate support.

Recent filings

Filing Released Lang Actions
Oliver Humlen utses till ny VD för ADDvise Group och efterträder Rikard Akhtarzand som övergår till en roll som styrelseledamot och aktiv aktieägare
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new CEO (Oliver Humlen) and the transition of the current CEO (Rikard Akhtarzand) to a board member role. This falls directly under the category of management changes and board-related announcements.
2024-05-02 Swedish
ADDvise receives order worth USD 11.3 million
Regulatory Filings Classification · 95% confidence The document is a press release announcing a new business contract/order worth USD 11.3 million for a subsidiary of ADDvise Group. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding business operations and is required to be disclosed under the EU Market Abuse Regulation, it falls under the general regulatory filing category.
2024-05-02 English
ADDvise erhåller order till ett värde av 11,3 miljoner USD
Regulatory Filings Classification · 95% confidence The document is a short press release announcing a specific business contract (an order worth 11.3 million USD) obtained by a subsidiary of ADDvise Group. It does not fit into financial reporting categories like 10-K or IR, nor is it a report publication announcement. As it is a general corporate announcement regarding business operations that does not fall into specific categories like M&A or dividends, it is classified as a general regulatory filing.
2024-05-02 Swedish
ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the publication of a prospectus for the admission of bonds to trading on Nasdaq Stockholm. It describes the issuance of bonds and the subsequent regulatory approval of the listing prospectus. Since it is an announcement regarding the availability of a document (the prospectus) and financing-related activities, it fits best under the Capital/Financing Update category.
2024-04-25 English
ADDvise offentliggör obligationsprospekt och ansöker om upptagande till handel av obligationer vid Nasdaq Stockholm
Capital/Financing Update Classification · 95% confidence The document is a short announcement (under 5,000 characters) regarding the publication of a bond prospectus and the application for trading on Nasdaq Stockholm. It follows the 'Menu vs Meal' rule, as it announces the availability of a document (the prospectus) rather than being the full report itself. It specifically relates to financing activities (bonds), making it a Capital/Financing Update.
2024-04-25 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for ADDvise Group for the period January 1 to March 31, 2024. It contains comprehensive financial statements, including income statements, balance sheets, segment reporting (Sjukvård and Lab), and management commentary on financial performance. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-04-18 Swedish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.